Do the cortisol results of a cosyntropin (ACTH) stimulation test—baseline 6.0 µg/dL, 30‑minute 14.5 µg/dL, and 60‑minute 19.2 µg/dL—indicate adrenal insufficiency?

Interpretation of Cosyntropin Stimulation Test Results

These results indicate normal adrenal function and exclude adrenal insufficiency. The 60‑minute cortisol of 19.2 µg/dL exceeds the FDA‑approved diagnostic threshold of 18 µg/dL and is well above contemporary assay‑specific cutoffs, confirming adequate adrenocortical reserve. 1

Test Result Analysis

Your cosyntropin stimulation test demonstrates:

• Baseline cortisol: 6.0 µg/dL (173 nmol/L)
• 30‑minute cortisol: 14.5 µg/dL (418 nmol/L)
• 60‑minute cortisol: 19.2 µg/dL (554 nmol/L)

Why This Result Is Normal

• The FDA‑approved threshold for excluding adrenal insufficiency is a stimulated cortisol ≥18 µg/dL at either 30 or 60 minutes post‑cosyntropin. 1 Your 60‑minute value of 19.2 µg/dL surpasses this cutoff, ruling out adrenal insufficiency.

• The 60‑minute cortisol is the most reliable time point for diagnosis. 2 The Endocrine Society guideline states that cosyntropin‑stimulated cortisol levels are slightly higher at 60 versus 30 minutes, and the 30‑minute time point has been validated against the insulin tolerance test. 2 However, the 60‑minute measurement provides greater diagnostic certainty and reduces false‑positive results. 3, 4

• Contemporary assay‑specific cutoffs are lower than the traditional 18 µg/dL threshold. For monoclonal antibody‑based immunoassays (Abbott Architect, Roche Elecsys II), the optimized 60‑minute cutoff is approximately 14.6 µg/dL (Abbott) or 485 nmol/L (Roche Elecsys II). 5, 6 Your result exceeds even the traditional threshold, making adrenal insufficiency extremely unlikely regardless of assay platform.

• The robust cortisol rise from baseline (6.0 µg/dL) to peak (19.2 µg/dL) demonstrates intact adrenal responsiveness. A stimulated cortisol >500 nmol/L (≈18 µg/dL) is accepted as evidence of sufficient adrenocortical function. 2, 7

Clinical Context and Next Steps

If This Test Was Ordered to Evaluate Suspected Primary Adrenal Insufficiency

• A peak cortisol >18 µg/dL makes primary adrenal insufficiency very unlikely. 7, 8 No further dynamic testing is needed. 2

• If clinical suspicion remains high despite a normal cosyntropin test, measure baseline plasma ACTH. 2 Primary adrenal insufficiency is characterized by ACTH >2‑fold the upper limit of normal (>66 pmol/L or >300 pg/mL) combined with low baseline cortisol (<5 µg/dL). 2, 8 Your baseline cortisol of 6.0 µg/dL is above the threshold for primary AI, but ACTH measurement can definitively exclude it. 2

If This Test Was Ordered During Glucocorticoid Taper

• Routine ACTH stimulation testing is not recommended for patients tapering glucocorticoids; morning cortisol alone is sufficient. 7, 9 However, since the test was performed, the result confirms recovery of the hypothalamic‑pituitary‑adrenal (HPA) axis. 7, 9

• A 60‑minute cortisol >18 µg/dL indicates that glucocorticoids can be safely discontinued. 7, 9 For glucocorticoid‑induced adrenal insufficiency, a morning cortisol >300 nmol/L (>10 µg/dL) predicts HPA recovery; your stimulated value far exceeds this threshold. 7, 9

If This Test Was Ordered to Evaluate Secondary (Central) Adrenal Insufficiency

• The 250 µg cosyntropin test cannot reliably distinguish primary from secondary adrenal insufficiency. 9 The supraphysiologic ACTH dose can temporarily overcome chronic ACTH deficiency and produce a falsely normal cortisol response, especially early in secondary AI before adrenal atrophy develops. 9

• Simultaneous measurement of baseline plasma ACTH is essential to differentiate primary from secondary causes. 2, 9 Secondary AI is suggested when baseline cortisol is low (<5 µg/dL) but ACTH is low or inappropriately normal (not elevated). 9, 8

• If secondary AI remains a concern despite a normal cosyntropin test, consider an insulin tolerance test or measure morning cortisol after glucocorticoid washout. 2, 9 However, your robust cortisol response makes clinically significant secondary AI unlikely. 9

Important Caveats

Factors That May Affect Test Interpretation

• Estrogen‑containing medications (including oral contraceptives) increase cortisol‑binding globulin (CBG), falsely elevating total cortisol levels. 1 If you are taking estrogen, the test should be repeated after stopping estrogen for 4–6 weeks, or free cortisol should be measured. 1

• Conditions that lower CBG (cirrhosis, nephrotic syndrome, critical illness) can falsely lower total cortisol. 1 In these settings, measure free cortisol or CBG levels to ensure accurate interpretation. 1

• Glucocorticoids and spironolactone should be stopped on the day of testing to avoid falsely elevated cortisol results. 1 Long‑acting glucocorticoids (dexamethasone, betamethasone) require a longer washout period. 1

When to Measure Baseline ACTH

• If clinical features suggest primary adrenal insufficiency (hyperpigmentation, salt craving, hyperkalemia, hyponatremia), measure baseline ACTH even with a normal cosyntropin test. 2, 8 ACTH >2‑fold the upper limit of normal confirms primary AI. 2, 8

• ACTH should be drawn simultaneously with baseline cortisol (before cosyntropin injection) to allow differentiation of primary versus secondary causes. 2, 9

Summary

Your cosyntropin stimulation test is unequivocally normal. The 60‑minute cortisol of 19.2 µg/dL exceeds all published diagnostic thresholds for adrenal insufficiency, including the FDA‑approved cutoff (18 µg/dL), contemporary assay‑specific cutoffs (14.6 µg/dL for Abbott, 485 nmol/L for Roche), and the Endocrine Society guideline threshold (500 nmol/L or 18 µg/dL). 2, 1, 5, 6 No further dynamic testing is required unless there are confounding factors (estrogen use, hypoalbuminemia) or persistent clinical suspicion warranting baseline ACTH measurement. 2, 1